From: Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
Marker expression | Patients (n) | Patients (%) | Median survival (months) | 5-Year survival (%) | P |
---|---|---|---|---|---|
CD 57 | Â | Â | Â | Â | Â |
 Low | 50 | 63 | 38 | 47 | 0.797 |
 High | 29 | 36 | 123 | 55 |  |
 Missing | 1 | 1 |  |  |  |
CD 68 | Â | Â | Â | Â | Â |
 Low | 34 | 43 | NR | 61 | 0.057 |
 High | 45 | 56 | 31 | 43 |  |
 Missing | 1 | 1 |  |  |  |
M-CSF | Â | Â | Â | Â | Â |
 Low | 36 | 45 | 75 | 54 | 0.608 |
 High | 39 | 49 | 36 | 46 |  |
 Missing | 5 | 6 |  |  |  |
CSF-1R | Â | Â | Â | Â | Â |
 Low | 36 | 45 | 52 | 49 | 0.587 |
 High | 37 | 46 | 57 | 47 |  |
 Missing | 7 | 9 |  |  |  |
Ki67 | Â | Â | Â | Â | Â |
 Low | 32 | 40 | NR | 74 | <0.001 |
 High | 37 | 46 | 29 | 35 |  |
 Missing | 11 | 14 |  |  |  |
TGF-beta | Â | Â | Â | Â | Â |
 Low | 43 | 54 | 52 | 50 | 0.906 |
 High | 28 | 35 | 31 | 50 |  |
 Missing | 9 | 11 |  |  |  |
M-CSF and TGF-beta | Â | Â | Â | Â | Â |
 Low | 24 | 30 | 80 | 57 | 0.626 |
 High | 42 | 53 | 31 | 45 |  |
 Missing | 14 | 18 |  |  |  |